Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure
*Department of Thoracic and Cardiovascular Surgery, Max-Planck-Institute Bad Nauheim, Germany
Department of Experimental Cardiology, Max-Planck-Institute Bad Nauheim, Germany
Received 10 September 1996; accepted 13 September 1996.
Correspondence: Dr Jutta Schaper, Department of Experimental Cardiology, Max-Planck-Institute, Benekestr. 2, D-61231 Bad Nauheim, Germany
Abstract
BACKGROUND: In the present study, the hypothesis was tested that cell adhesion molecules are expressed in failing human hearts and that a chronic inflammatory process contributes to chronic degeneration known to occur in cardiac incompetence. The cell adhesion molecules: ICAM-1, VCAM-1, PECAM-1, and E-selectin were studied, in addition to cellular markers of inflammation.
METHODS AND RESULTS: Tissue was obtained at transplantation from patients with either myocarditis, chronic ischaemic heart disease, or dilated cardiomyopathy. Controls were taken from patients with normal ventricles. Cell adhesion molecules were qualitatively evaluated and counted using specific antibodies and confocal microscopy. Additionally, semiquantitative evaluation of the presence of the CD3 antigen (T-lymphocytes), CD68 (macrophages), CD11a/CD18 (ICAM-1 receptor) and human tumour necrosis factor-
were used as indicators of chronic inflammation. PECAM-1 stained all endothelial cells but ICAM-1 was only present in 80% of all capillaries in control tissue. The ratio ICAM-1/PECAM-1 was significantly enhanced in all groups of diseased hearts. Myocytes in myocarditic hearts expressed ICAM-ICAM. CD3 positive lymphocytes, CD68 positive macrophages and CD11a/;CD18 positive cells were more abundantly present than in control. Macrophages expressing tumour necrosis factor- were found in failing myocardium but not in control tissue.
CONCLUSION: Independent of the cause of heart failure, chronic low grade inflammation is present in failing human myocardium. This may significantly contribute to the structural deterioration that is the basis of reduced cardiac function in congestive heart failure.
Key Words: Cell adhesion molecules • heart failure • inflammation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Kistorp, A. Y. Chong, F. Gustafsson, S. Galatius, I. Raymond, J. Faber, G. Y.H. Lip, and P. Hildebrandt Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes Eur J Heart Fail, April 1, 2008; 10(4): 380 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Stumpf, C Lehner, D Raaz, A Yilmaz, T Anger, W G Daniel, and C D Garlichs Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure Heart, January 1, 2008; 94(1): 65 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Deng, B. Kulle, M. Hosseini, G. Schluter, G. Hasenfuss, L. Wojnowski, and A. Schmidt Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity Eur J Heart Fail, October 1, 2007; 9(10): 986 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Reifenberg, H.-A. Lehr, M. Torzewski, G. Steige, E. Wiese, I. Kupper, C. Becker, S. Ott, P. Nusser, K.-I. Yamamura, et al. Interferon-{gamma} Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice Am. J. Pathol., August 1, 2007; 171(2): 463 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Westphal, Li Chen, C. Pilowski, S. Koch, H. Ebelt, U. Muller-Werdan, K. Werdan, and H. Loppnow Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1{alpha} Innate Immunity, February 1, 2007; 13(1): 25 - 34. [Abstract] [PDF]
|
|
|
|
|
|
K. Toutouzas, P. Stougiannos, M. Drakopoulou, J. Mitropoulos, E. Bosinakou, V. Markou, G. Latsios, I. Karabelas, E. Stefanadi, and C. Stefanadis Coronary sinus thermography in idiopathic dilated cardiomyopathy: Correlation with systemic inflammation and left ventricular contractility Eur J Heart Fail, February 1, 2007; 9(2): 168 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. van Kimmenade, J. L. Januzzi Jr, P. T. Ellinor, U. C. Sharma, J. A. Bakker, A. F. Low, A. Martinez, H. J. Crijns, C. A. MacRae, P. P. Menheere, et al. Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1217 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, G. Takemura, H. Okada, S. Miyata, R. Maruyama, L. Li, M. Higuchi, S. Minatoguchi, T. Fujiwara, and H. Fujiwara Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure Cardiovasc Res, September 1, 2006; 71(4): 684 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Niebauer, A. L. Clark, K. M. Webb-Peploe, and A. J.S. Coats Exercise training in chronic heart failure: effects on pro-inflammatory markers Eur J Heart Fail, March 2, 2005; 7(2): 189 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D Anker and S. von Haehling Inflammatory mediators in chronic heart failure: an overview Heart, April 1, 2004; 90(4): 464 - 470. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Delgado III, M. A. Nawar, A. M. Zewail, B. Kar, W. K. Vaughn, K. K. Wu, N. Aleksic, N. Sivasubramanian, K. McKay, D. L. Mann, et al. Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure Circulation, March 23, 2004; 109(11): 1428 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Adamopoulos, J. T. Parissis, I. Paraskevaidis, D. Karatzas, E. Livanis, M. Georgiadis, G. Karavolias, D. Mitropoulos, D. Degiannis, and D. Th. Kremastinos Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy Eur. Heart J., December 2, 2003; 24(24): 2186 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy Eur J Heart Fail, August 1, 2003; 5(4): 469 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. Yin, J.-W. Chen, H.-L. Jen, M.-C. Chiang, W.-P. Huang, A.-N. Feng, S.-J. Lin, and M. S. Young The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure Eur J Heart Fail, August 1, 2003; 5(4): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Li, C.-S. Tsai, S.-H. Chueh, P.-C. Hsu, J.-Y. Wang, C.-S. Wong, and S.-T. Ho Dobutamine Inhibits Monocyte Chemoattractant Protein-1 Production and Chemotaxis in Human Monocytes Anesth. Analg., July 1, 2003; 97(1): 205 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kostin, L. Pool, A. Elsasser, S. Hein, H. C.A. Drexler, E. Arnon, Y. Hayakawa, R. Zimmermann, E. Bauer, W.-P. Klovekorn, et al. Myocytes Die by Multiple Mechanisms in Failing Human Hearts Circ. Res., April 18, 2003; 92(7): 715 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Egashira Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1 Hypertension, March 1, 2003; 41(3): 834 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yun, M. J Zuscik, P. Gonzalez-Cabrera, D. F McCune, S. A Ross, R. Gaivin, M. T Piascik, and D. M Perez Gene expression profiling of {alpha}1b-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays Cardiovasc Res, February 1, 2003; 57(2): 443 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl Advances in the immunohistological diagnosis of inflammatory cardiomyopathy Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I54 - I62. [Abstract] [PDF]
|
|
|
|
|
|
S. Zeuke, A. J Ulmer, S. Kusumoto, H. A Katus, and H. Heine TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS Cardiovasc Res, October 1, 2002; 56(1): 126 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nakamura, K. Egashira, Y. Machida, S. Hayashidani, M. Takeya, H. Utsumi, H. Tsutsui, and A. Takeshita Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart Failure: Roles of Oxidative Stress and Inflammation Circulation, July 16, 2002; 106(3): 362 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. El-Solh, M. J. Mador, P. Sikka, R. S. Dhillon, D. Amsterdam, and B. J. B. Grant Adhesion Molecules in Patients With Coronary Artery Disease and Moderate-to-Severe Obstructive Sleep Apnea* Chest, May 1, 2002; 121(5): 1541 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yndestad, J. Kristian Damas, H. Geir Eiken, T. Holm, T. Haug, S. Simonsen, S. S. Froland, L. Gullestad, and P. Aukrust Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure Cardiovasc Res, April 1, 2002; 54(1): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adamopoulos, J. Parissis, D. Karatzas, C. Kroupis, M. Georgiadis, G. Karavolias, J. Paraskevaidis, K. Koniavitou, A. J. S. Coats, and D. T. Kremastinos Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure J. Am. Coll. Cardiol., February 20, 2002; 39(4): 653 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Mahon, B. P. Madden, A. L. P. Caforio, P. M. Elliott, A. J. Haven, B. E. Keogh, M. J. Davies, and W. J. McKenna Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 6, 2002; 39(3): 455 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adamopoulos, J. T. Parissis, and D. Th. Kremastinos A glossary of circulating cytokines in chronic heart failure Eur J Heart Fail, October 1, 2001; 3(5): 517 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Valen, Z.-q. Yan, and G.o. K. Hansson Nuclear factor kappa-B and the heart J. Am. Coll. Cardiol., August 1, 2001; 38(2): 307 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. KIMURA, O. OKADA, N. TANABE, Y. TANAKA, M. TERAI, Y. TAKIGUCHI, M. MASUDA, N. NAKAJIMA, K. HIROSHIMA, H. INADERA, et al. Plasma Monocyte Chemoattractant Protein-1 and Pulmonary Vascular Resistance in Chronic Thromboembolic Pulmonary Hypertension Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 319 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Damas, L. Gullestad, H. Aass, S. Simonsen, J. G. Fjeld, L. Wikeby, T. Ueland, H. G. Eiken, S. S. Froland, and P.a. Aukrust Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure--modulatory effect of intravenous immunoglobulin J. Am. Coll. Cardiol., July 1, 2001; 38(1): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Adamopoulos, J Parissis, C Kroupis, M Georgiadis, D Karatzas, G Karavolias, K Koniavitou, A.J.S Coats, and D.T. Kremastinos Physical training reduces peripheral markers of inflammation in patients with chronic heart failure Eur. Heart J., May 1, 2001; 22(9): 791 - 797. [Abstract] [PDF]
|
|
|
|
|
|
L. Gullestad, H. Aass, J. G. Fjeld, L. Wikeby, A. K. Andreassen, H. Ihlen, S. Simonsen, J. Kjekshus, S. Nitter-Hauge, T. Ueland, et al. Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure Circulation, January 16, 2001; 103(2): 220 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Damas, H. G. Eiken, E. Oie, V. Bjerkeli, A. Yndestad, T. Ueland, T. Tonnessen, O. R. Geiran, H. Aass, S. Simonsen, et al. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure Cardiovasc Res, September 1, 2000; 47(4): 778 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Valen, G. Paulsson, A. M. Bennet, G. K. Hansson, and J. Vaage Gene expression of inflammatory mediators in different chambers of the human heart Ann. Thorac. Surg., August 1, 2000; 70(2): 562 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Damas, L. Gullestad, T. Ueland, N. O. Solum, S. Simonsen, S. S Froland, and P. Aukrust CXC-chemokines, a new group of cytokines in congestive heart failure -- possible role of platelets and monocytes Cardiovasc Res, January 14, 2000; 45(2): 428 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Serebruany, S. R. Murugesan, A. Pothula, D. Atar, D. R. Lowry, C. M. O'Connor, and P. A. Gurbel Increased soluble platelet / endothelial cellular adhesion molecule-1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy Eur J Heart Fail, August 31, 1999; 1(3): 243 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Noutsias, B. Seeberg, H.-P. Schultheiss, and U. Kuhl Expression of Cell Adhesion Molecules in Dilated Cardiomyopathy : Evidence for Endothelial Activation in Inflammatory Cardiomyopathy Circulation, April 27, 1999; 99(16): 2124 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Aukrust, T. Ueland, F. Muller, A. K. Andreassen, I. Nordoy, H. Aas, J. Kjekshus, S. Simonsen, S. S. Froland, and L. Gullestad Elevated Circulating Levels of C-C Chemokines in Patients With Congestive Heart Failure Circulation, March 31, 1998; 97(12): 1136 - 1143. [Abstract] [Full Text] [PDF]
|
|